Abstract:Until recently, low accumulation levels have been the major bottleneck for plant-made recombinant protein production. However, several breakthroughs have been described in the past few years allowing for very high accumulation levels, mainly through chloroplast transformation and transient expression, coupled with subcellular targeting and protein fusions. Another important factor influencing our ability to use plants for the production of recombinant proteins is the availability of quick and simple purification strategies. Recent developments using oleosin, zein, ELP and hydrophobin fusion tags have shown promise as efficient and cost-effective methods for non-chromatographic separation. Furthermore, plant glycosylation is a major barrier to the parenteral administration of plant-made biopharmaceuticals because of potential immunogenicity concerns. A major effort has been invested in humanizing plant glycosylation, and several groups have been able to reduce or eliminate immunogenic glycans while introducing mammalian-specific glycans. Finally, biosafety issues and public perception are essential for the acceptance of plants as bioreactors for the production of proteins. Over recent years, it has become clear that food and feed plants carry an inherent risk of contaminating our food supply, and thus much effort has focused on the use of non-food plants. Presently, Nicotiana benthamiana has emerged as the preferred host for transient expression, while tobacco is most frequently used for chloroplast transformation. In this review, we focus on the main issues hindering the economical production of recombinant proteins in plants, describing the current efforts for addressing these limitations, and we include an extensive list of recent patents generated with the intention of solving these limitations.

Biotechnological advances in the production of unusual fatty acids in transgenic plants and recombinant microorganisms

Advances in Synthetic Biology Tools Paving the Way for the Biomanufacturing of Unusual Fatty Acids Using the Yarrowia Lipolytica Chassis

Enrichment of Long-Chain Polyunsaturated Fatty Acids by Coordinated Expression of Multiple Metabolic Nodes in the Oleaginous Microalga Phaeodactylum Tricornutum

An Overview of the Production of Long Chain Poly-Unsaturated Fatty Acids in Higher Plants by Genetic Engineering

Cellular Engineering Strategies Toward Sustainable Omega-3 Long Chain Polyunsaturated Fatty Acids Production: State of the Art and Perspectives.

Recent advances in biotechnological production of polyunsaturated fatty acids by <i>Yarrowia lipolytica</i>

Engineering Microbes to Produce Polyunsaturated Fatty Acids.

Recent advances in biotechnological production of polyunsaturated fatty acids by Yarrowia lipolytica

Universal and unique strategies for the production of polyunsaturated fatty acids in industrial oleaginous microorganisms

Plant Unsaturated Fatty Acids: Biosynthesis and Regulation

Biotechnology in Future Food Lipids: Opportunities and Challenges

Genetic Engineering of Plant Oil

Biosynthesis of Very-Long-Chain Polyunsaturated Fatty Acids in Transgenic Oilseeds: Constraints on Their Accumulationw⃞

Harnessing the Lipogenic Potential of Δ6-Desaturase for Simultaneous Hyperaccumulation of Lipids and Polyunsaturated Fatty Acids in Nannochloropsis Oceanica

Divergent evolution of extreme production of variant plant monounsaturated fatty acids

High-value Bioproducts from Microalgae: Strategies and Progress

Enhancement of lipid accumulation in microalgae by metabolic engineering

A state-of-the-art review on the synthetic mechanisms, production technologies, and practical application of polyunsaturated fatty acids from microalgae

Yarrowia lipolytica as a biotechnological chassis to produce usual and unusual fatty acids

Green biofactories: recombinant protein production in plants

Microbial production of odd‐chain fatty acids